Article

Bladder cancer risk stratification with the Oncuria 10-plex bead-based urinalysis assay using three different Luminex xMAP instrumentation platforms

2023-11-25

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold> No single marker of bladder cancer (BC) exists in urine samples with sufficient accuracy for disease diagnosis and treatment monitoring. The multiplex Oncuria BC assay noninvasively quantifies the concentration of 10 protein analytes in voided urine samples to quickly generate a unique molecular profile with proven BC diagnostic and treatment-tracking utility. T...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 456d5fb8-a858-5414-bda6-468b1a15fe8c
DOI: 10.21203/rs.3.rs-3635581/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Bladder cancer risk stratification with the Oncuria 10-plex bead-based urinalysis assay using three different Luminex xMAP instrumentation platformsDOI 10.21203/rs.3.rs-3635581/v1Read

Non-Invasive Urine-Based Diagnostic Technologies for Early Bladder CancerSemantic proximity Read

GALEAS™ Bladder Demonstrates High Sensitivity and Specificity for Detecting Bladder Cancer: Real-World Multicentre Data from UK NHS Haematuria ClinicsSemantic proximity Read

A systematic review on diagnostic and prognostic biomarkers for bladder cancerSemantic proximity Read

Urinary Biomarkers in Bladder Cancer: FDA-Approved Tests and Emerging Tools for Diagnosis and SurveillanceSemantic proximity Read

Trends in urine biomarker discovery for urothelial bladder cancer: DNA, RNA, or protein?Semantic proximity Read

Non-Invasive Diagnostic Evaluation of Urinary Exosomal Let-7c Cluster Expression in Bladder Cancer Using Machine Learning ApproachesSemantic proximity Read

Urinary Biomarkers in Urothelial Carcinoma: Expanded Con-temporary Evidence for Diagnosis, Surveillance, Risk Stratification, and Cystoscopy-Sparing Clinical PathwaysSemantic proximity Read

Urinary peptidomic signatures predict overall and progression-free survival in patients with bladder cancerSemantic proximity Read

Current and emerging bladder cancer biomarkers with an emphasis on urine biomarkersSemantic proximity Read

Improving diagnostic molecular tests to monitor urothelial carcinoma recurrence.Semantic proximity Read

Validation of a microRNA profile in urine liquid biopsy with diagnostic and stratification value for bladder cancer classification, available through the open app BladdermiRaCanSemantic proximity Read

Bladder cancer detection in urine by novel methylation markersSemantic proximity Read